arrow_back Back to App

Increased Transparency for 340B Drug Discount Program

New rules enhance oversight of the 340B drug discount program, requiring healthcare facilities to report how they use savings from drug purchases. This aims to ensure that discounts genuinely benefit patients, especially those with limited means, and to increase public access to information about the program.
Key points
Healthcare facilities must report how they use savings from discounted drug purchases, ensuring funds benefit patients.
Information on discount usage will be publicly available, allowing citizens to see how facilities manage funds.
Financial penalties are introduced for non-compliance with new reporting rules, aiming for greater program discipline and transparency.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_3290
Sponsor: Rep. Bucshon, Larry [R-IN-8]
Process start date: 2023-05-15